Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)

Clinical trial NCT00761007 · COMPLETED

Trial details

NCT number: NCT00761007
Sponsor: Menarini Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2008-07-01
Primary completion: 2009-02-01
Enrollment: 554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.